ArticleFrontiers in oncology2021

Bortezomib Inhibits Multiple Myeloma Cells by Transactivating ATF3 to Trigger miR-135a-5p- Dependent Apoptosis.

Xiaolan Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.